View in EDS HTML Full Text PDF Full Text

Defining Biological and Clinical Plausibility: The DICSA Framework for Protocolized Assessment in Survival Extrapolations Across Therapeutic Areas.

Saved in:
Bibliographic Details
Title: Defining Biological and Clinical Plausibility: The DICSA Framework for Protocolized Assessment in Survival Extrapolations Across Therapeutic Areas.
Authors: Heeg B; Cytel, 3012 NJ, Rotterdam, The Netherlands. bart.heeg@cytel.com., Lee D; University of Exeter Medical School, South Cloisters, St Luke's Campus, Exeter, EX1 2LU, UK., Adam J; St George'S Hospital, Blackshaw Road, London, SW17 0QT, UK., Postma M; Unit of Global Health, Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.; Department of Economics, Econometrics and Finance, Faculty of Economics and Business, Groningen, University of Groningen, The Netherlands Nettelbosje 2, 9747 AE, Groningen, The Netherlands.; Center of Excellence for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia.; Division of Pharmacology and Therapy, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia., Ouwens M; Real World Science and Analytics, Astrazeneca Global, Västergötland, Sweden.
Source: PharmacoEconomics [Pharmacoeconomics] 2025 Jul; Vol. 43 (7), pp. 793-803. Date of Electronic Publication: 2025 Mar 29.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40156682
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Defining Biological and Clinical Plausibility: The DICSA Framework for Protocolized Assessment in Survival Extrapolations Across Therapeutic Areas.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Heeg+B%22">Heeg B</searchLink>; Cytel, 3012 NJ, Rotterdam, The Netherlands. bart.heeg@cytel.com.<br /><searchLink fieldCode="AU" term="%22Lee+D%22">Lee D</searchLink>; University of Exeter Medical School, South Cloisters, St Luke's Campus, Exeter, EX1 2LU, UK.<br /><searchLink fieldCode="AU" term="%22Adam+J%22">Adam J</searchLink>; St George'S Hospital, Blackshaw Road, London, SW17 0QT, UK.<br /><searchLink fieldCode="AU" term="%22Postma+M%22">Postma M</searchLink>; Unit of Global Health, Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.; Department of Economics, Econometrics and Finance, Faculty of Economics and Business, Groningen, University of Groningen, The Netherlands Nettelbosje 2, 9747 AE, Groningen, The Netherlands.; Center of Excellence for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia.; Division of Pharmacology and Therapy, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.<br /><searchLink fieldCode="AU" term="%22Ouwens+M%22">Ouwens M</searchLink>; Real World Science and Analytics, Astrazeneca Global, Västergötland, Sweden.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229212404%22">PharmacoEconomics</searchLink> [Pharmacoeconomics] 2025 Jul; Vol. 43 (7), pp. 793-803. <i>Date of Electronic Publication: </i>2025 Mar 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9212404 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-2027 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211707690%22">11707690 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacoeconomics <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40156682
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40273-025-01485-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 793
    Titles:
      – TitleFull: Defining Biological and Clinical Plausibility: The DICSA Framework for Protocolized Assessment in Survival Extrapolations Across Therapeutic Areas.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Heeg B
      – PersonEntity:
          Name:
            NameFull: Lee D
      – PersonEntity:
          Name:
            NameFull: Adam J
      – PersonEntity:
          Name:
            NameFull: Postma M
      – PersonEntity:
          Name:
            NameFull: Ouwens M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1179-2027
          Numbering:
            – Type: volume
              Value: 43
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: PharmacoEconomics
              Type: main
ResultId 1